Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients

Liebowitz, 1994, Nasopharyngeal carcinoma: the Epstein-Barr virus association, Semin Oncol, 21, 376 Fingeroth, 1984, Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2, 81, 4510 Sixbey, 1984, Epstein-Barr virus replication in oropharyngeal epithelial cells, N Engl J Med, 310, 1225, 10.1056/NEJM198405103101905 Sixbey, 1992, Immunoglobulin A-induce shift of Epstein-Barr virus tissue tropism, Science, 255, 1578, 10.1126/science.1312750 Niedobitek, 1994, Epstein—Barr virus persistence and virus-associated tumours, Lancet, 343, 333, 10.1016/S0140-6736(94)91167-3 Raab-Traub, 1987, The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA, Int J Cancer, 39, 25, 10.1002/ijc.2910390106 Pearson, 1983, Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinomas, Cancer, 51, 260, 10.1002/1097-0142(19830115)51:2<260::AID-CNCR2820510216>3.0.CO;2-# Ambinder, 1994, Detection and characterization of Epstein-Barr virus in clinical specimens, Am J Pathol, 145, 239 Hudson, 1985, Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8, J Virol, 53, 528, 10.1128/JVI.53.2.528-535.1985 Wang, 1985, An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells, Cell, 43, 831, 10.1016/0092-8674(85)90256-9 Rowe, 1987, Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells, J Gen Virol, 68, 1575, 10.1099/0022-1317-68-6-1575 Shanmugaratnam, 1978, Histological Typing of Upper Respiratory Tract Tumours U.I.C.C., 1992 Wood, 1981, Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems, J Histochem Cytochem, 29, 1196, 10.1177/29.10.7028859 Lauritzen, 1994, Epstein-Barr virus and Hodgkin's disease. A comparative immunological, in situ hybridization and polymerase chain reaction study, APMIS, 102, 495, 10.1111/j.1699-0463.1994.tb05196.x Maniatis, 1982 1990 Cinque, 1993, Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system, Lancet, 342, 398, 10.1016/0140-6736(93)92814-A Telenti, 1990, Detection of Epstein-Barr virus by polymerase chain reaction, J Clin Microbiol, 28, 2187, 10.1128/JCM.28.10.2187-2190.1990 Hubbert, 1982, De The G. Comportement alimentaire, modes de vie et cancer de rhinopharynx, Bull Cancer, 69, 476 Dickens, 1992, Epstein-Barr virus DNA in nasopharyngeal carcinomas from Chinese patients in Hong Kong, J Clin Pathol, 45, 396, 10.1136/jcp.45.5.396 Yeung, 1993, Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ, Int J Cancer, 53, 746, 10.1002/ijc.2910530507 Hørding, 1993, Nasopharyngeal carcinoma: histopathological types and association with Epstein-Barr virus, Oral Oncol, Eur J Cancer, 29B, 137, 10.1016/0964-1955(93)90036-E Pathmanathan, 1995, Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia, Am J Pathol, 146, 1355 Della Torre, 1994, Epstein-Barr virus genomes in undifferentiated and squamous cell nasopharyngeal carcinomas in Italian patients, Diagn Mol Pathol, 3, 32, 10.1097/00019606-199403010-00006 Pallensen, 1991, Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease, Lancet, 337, 320, 10.1016/0140-6736(91)90943-J Fåhraeus, 1988, Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma, Int J Cancer, 42, 329, 10.1002/ijc.2910420305 Young, 1988, Epstein-Barr virus gene expression in nasopharyngeal carcinoma, J Gen Virol, 69, 1051, 10.1099/0022-1317-69-5-1051 Niedobitek, 1992, Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas, Am J Pathol, 140, 879 Zheng, 1994, Expression of Ki 67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP-1) in nasopharyngeal carcinoma, Oral Oncol, Eur J Cancer, 30B, 290, 10.1016/0964-1955(94)90027-2 Hu, 1993, Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP-1, Oncogene, 8, 1575 Trivedi, 1994, Epstein-Barr(EBV)-encoded membrane protein LMP-1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue, Eur J Cancer, 30A, 84, 10.1016/S0959-8049(05)80024-3 Hu, 1991, Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5′-flanking region, J Virol, 65, 1558, 10.1128/JVI.65.3.1558-1567.1991 Jiwa, 1995, Immunohistochemical demonstration of different latent membrane proteins-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases, J Clin Pathol, 48, 438, 10.1136/jcp.48.5.438